Revolutionary TB Vaccine Advances After Funding Boost From Gates, Wellcome
By Sunday Isuwa The groundbreaking progress in the development of a new tuberculosis (TB) vaccine, M72/AS01E (M72), as Wellcome and the Bill & Melinda Gates Foundation provide substantial funding for a Phase III clinical trial. We explore the potential impact of the vaccine on combating the global TB crisis, emphasizing the urgent need for new…